What is the molecular mechanism behind the treatment of Myasthenia gravis with Acetylcholinesterase inbibitor?

Myasthenia gravis is an autoimmune disease, that affect the cholinergic receptor and also in some variant muscle specific kinase. More Acetylcholine against reduced and unavailable receptor......?...

26 September 2019 2,178 1 View